Yüklüyor......

Adherence to lenalidomide in older adults with newly-diagnosed multiple myeloma

INTRODUCTION: One of the most common orally administered anti-myeloma agent, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Lymphoma Myeloma Leuk
Asıl Yazarlar: Mian, Hira, Fiala, Mark, Wildes, Tanya M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564009/
https://ncbi.nlm.nih.gov/pubmed/31843543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.09.618
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!